Generex Biotechnology Corporation

Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that it advised Generex Biotechnology Corporation ("Generex") (OTCMKTS: GNBT) on the first tranche acquisition of certain operating assets from Veneto Holdings, L.L.C. ("Veneto") and certain of its affiliated entities (collectively, the "Veneto Group").

First Tranche Acquisition

Brooks Houghton

Healthcare / Pharmaceuticals / MedTech / Lifescience

Date completed

Target company
Veneto Holdings, LLC

Target country

Acquirer company
Generex Biotechnology Corporation

Acquirer country

Get in touch and let's talk about how we could help your business.

Get Started